leisure time -WSS

leisure time

author：leisure time 2025-10-04 03:59:29 - browse：53887

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How should state employee insurance handle Wegovy?

WSS

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Carbon Health diabetes program, a test of data

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Type 2 diabetes prevention programs work at large scale: study

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

What's changing in Medicare's open enrollment this year?

entertainment

leisure time

focus

Wildfire smoke exposes gaps in outdoor worker protections

Female surgeons have lower rates of long

Cancer drug shortages should be causing more outrage

A letter from the executive editor: STAT UnitedHealth investigation

Apple is now the first public company to be valued at $3 trillion

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Duchenne breakthrough therapy leaves behind pioneering families

Ventyx halts psoriasis drug development after lackluster trial results

Jerome Adams on the need for new antivirals for Covid

First transplant of an entire human eye performed

Wikipedia

Life sciences deals on track to hit lowest point since 2017

Publishing genetic code of viruses could cause disaster

STAT Readout: Today's biotech news includes Sana and Amylyx

Humana CEO Bruce Broussard to step down in 2024

What is STAT's opinion section for?

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

focus

leisure time

leisure time

focus